Viewing Study NCT07105059


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-02-27 @ 1:09 PM
Study NCT ID: NCT07105059
Status: RECRUITING
Last Update Posted: 2025-11-28
First Post: 2025-07-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module